Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptide peptidase-like 2C (SPPL2C) is an intramembrane aspartyl protease of the SPP/SPPL family, categorized by conserved 'YD' and 'GxGD' active site motifs located within transmembrane domains[5][2]. SPPL2C is primarily and highly expressed in the testes—particularly in spermatids—of mouse and human, where it supports male germ cell differentiation, vesicular trafficking, acrosome formation, and Ca²⁺ regulation through proteolytic cleavage of specific substrates such as phospholamban and SNARE proteins[2][3][6][7]. While other family members such as SPPL2A and SPPL2B have known immunological or pathophysiological roles, SPPL2C’s loss in mice leads to partial defects in spermatid maturation and reduced sperm motility, but maintains overall fertility. No direct human disease associations or connections to drug targeting, biomarkers, or safety concerns have been established as of current knowledge[2][4].
Proteolytic cleavage of transmembrane or tail-anchored proteins (e.g., SNARE proteins, phospholamban/PLN)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptide peptidase-like 2C (SPPL2C).